Circle Pharma
Gabriel is a Scientist with experience in solid-phase synthesis of peptides as well as solution-phase synthesis of small molecules. He received his B.S. in Chemistry from UC Berkeley, and Ph.D in Organic Chemistry under Dr. Lam from UC Davis, where he worked on the combinatorial library syntheses of Actinomycin D analogs bearing triazoles. Prior to graduate school, he lectured sophomore Organic Chemistry and Biochemistry at San Francisco State University.
This person is not in any offices
Circle Pharma
2 followers
Circle Pharma, Inc. initiated operations in June 2014 with seed funding from Pfizer, Inc. and Mission Bay Capital, LLP; we received additional seed funding from ShangPharma Investment Group Limited in November 2015. We recently raised Series B and Series C financing from The Column Group and NextTech Invest.